A Study of Evacetrapib in Healthy Female Participants
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effects of evacetrapib on oral contraceptives
(Ortho-Cyclen®) when given to healthy female participants. The amount of female hormones
found in the blood will be measured and compared when taken alone and when taken with
evaceptrapib. Each woman will participate in two study periods. Information about any side
effects that may occur will also be collected.
Phase:
Phase 1
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Evacetrapib Fluoroquinolones Moxifloxacin Norgestimate, ethinyl estradiol drug combination